Gadolinium Toxicity Testing
Gadolinium element is used in the making of Gadolinium-based contrast agents (GBCAs) which are used in MRI or MRA scans. Medical professionals have used GBCAs since 1988 for between 33-50% of all exams and was considered to be safe. Now, reports indicate that the body retains the chemical in the body and in some cases have adverse side effects. If you suspect the accumulation of this element, it is important to know how to receive gadolinium toxicity testing.
About Gadolinium Toxicity
The FDA conducted a review of the AERS database along with additional literature and found many reports of gadolinium toxicity. Many develop side effects within hours of a scan. These side effects include pain and burning sensation at the origin site, cognitive difficulties, central nervous system problems and skin and musculoskeletal complaints. Many end up bedridden or in wheelchairs due to their loss of mobility and pain. It doesn’t matter a patient’s health beforehand. Top level athletes or young parents have been unable to work again after gadolinium toxicity. Treatments are costly, and there is not a cure.
Types of Gadolinium Toxicity Testing
There are three main avenues for those suspecting gadolinium toxicity testing to confirm their body is retaining the deadly MRI contrast dye. These are urine, blood, and dermal tests.
Urine testing is the first step to a gadolinium toxicity diagnosis. It may not be definitive, however. High levels of gadolinium only show proof of retaining the chemical agent. Also, having a lower level of the chemical does not mean there weren’t high levels previously. Patients can take the test for differing lengths of time, but a 24-hour collection sample provides the most consistent results. It also reduces the chance of variables.
A doctor may request the 24-hour urine test through testing agencies like Quest Diagnostics or Lab Corp. The test is around $100. However, there are online options for testing for toxic metals if a medical professional will not order the test.
This is the least-invasive, and simplest way to determine if there are elevated levels of gadolinium.
Blood test for gadolinium toxicity is another option. However, the plasma half-life of Gadolinium is approximately 90 minutes. The Mayo Clinic states that elevated gadolinium more than four days after GBCA administration is not typical of most patients with normal renal function. Blood tests often report undetectable levels when urine tests indicate elevated levels of Gadolinium.
Dermal biopsies were a common way to diagnosis gadolinium toxicity in patients with neural systemic fibrosis (NSF). NSF is not the same as GDD, however, there are similarities since both illnesses involve the chemical’s retention. Dermatopathology labs will test any skin changes for gadolinium toxicity. Insurance may not cover this test, or labs may not offer it independently either. A researcher willing to test tissue specimens for evidence of gadolinium would need to complete it.
A gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.
For more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no-obligation consultations. We have also over 20 years experience helping consumers injured by unsafe products manufactured by large companies.